arrow
M

Mariëtte Hooiveld

public health institute of navarra
H指数:29
被引数:2,800

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022-2024

2022-2024年欧洲初级保健儿科诊所流感疫苗有效性

2026-05-010
PRE
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

关于接种后时间对疫苗效力估计与报告的建议:一项COVID-19病例研究

2025-11-170
OA
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population

由于一般人群中SARS-CoV-2测试的可用性,在初级保健水平的新型冠状病毒肺炎疫苗有效性研究中引入了潜在的偏差

2025-08-012
OA
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network

欧洲目标人群中针对需要医疗干预的SARS-CoV-2症状性感染的COVID-19疫苗有效性(2024年10月至2025年1月,VEBIS初级保健网络)

2025-05-210
OA
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024

XBB.1.5疫苗对老年人症状性SARS-CoV-2感染的有效性在JN.1谱系优势时期,欧洲VEBIS初级保健多中心研究,2024 2023年11月20日-3月1日

2024-11-100
OAAI
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
2024-03-286
OAAI
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

中期2023/24甲型流感疫苗有效性: VEBIS欧洲初级保健和医院多中心研究,2023年9月2024年1月

2024-02-2211
OAAI
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

欧洲流感疫苗的有效性: 2022 2023 VEBIS (疫苗有效性,负担和影响研究) 初级保健多中心研究的结果

2024-01-107
OAAI
Inference of age-dependent case-fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands

使用来自荷兰的数据推断季节性流感病毒亚型A(H3N2) 和A(H1N1)pdm09和B谱系的年龄依赖性病死率

2023-06-195
OA
An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant Staphylococcus aureus with additional resistance to fusidic acid, June 2018 to January 2020
2022-12-086
OAAI
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study

欧洲流感疫苗对甲型流感亚型的有效性: 2021 2022的i-move初级保健多中心研究的结果

2022-11-2123
OA
Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned

2020年上半年在欧洲七个国家迅速调整初级保健哨点监测以新型冠状病毒肺炎: 优势,挑战和经验教训

2022-06-3017
OAAI
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
2022-05-2618
OAAI